Previous Article | Next Article 
Journal of Virology, March 1999, p. 2094-2098, Vol. 73, No. 3
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
DNA Vaccine Encoding Hemagglutinin Provides
Protective Immunity against H5N1 Influenza Virus Infection in
Mice
Shantha
Kodihalli,1,*
Hideo
Goto,2
Darwyn L.
Kobasa,1
Scott
Krauss,1
Yoshihiro
Kawaoka,2 and
Robert
G.
Webster1
Department of Virology and Molecular Biology,
St. Jude Children's Research Hospital, Memphis, Tennessee
38105,1 and
Department of
Pathobiological Sciences, School of Veterinary Medicine, University
of Wisconsin
Madison, Madison, Wisconsin 537062
Received 23 September 1998/Accepted 11 November 1998
In Hong Kong in 1997, a highly lethal H5N1 avian influenza virus
was apparently transmitted directly from chickens to humans with no
intermediate mammalian host and caused 18 confirmed infections and six
deaths. Strategies must be developed to deal with this virus if it
should reappear, and prospective vaccines must be developed to
anticipate a future pandemic. We have determined that unadapted H5N1
viruses are pathogenic in mice, which provides a well-defined mammalian
system for immunological studies of lethal avian influenza virus
infection. We report that a DNA vaccine encoding hemagglutinin from the
index human influenza isolate A/HK/156/97 provides immunity against
H5N1 infection of mice. This immunity was induced against both the
homologous A/HK/156/97 (H5N1) virus, which has no glycosylation site at
residue 154, and chicken isolate A/Ck/HK/258/97 (H5N1), which does have
a glycosylation site at residue 154. The mouse model system should
allow rapid evaluation of the vaccine's protective efficacy in a
mammalian host. In our previous study using an avian model, DNA
encoding hemagglutinin conferred protection against challenge with
antigenic variants that differed from the primary antigen by 11 to 13%
in the HA1 region. However, in our current study we found that a DNA
vaccine encoding the hemagglutinin from A/Ty/Ir/1/83 (H5N8), which
differs from A/HK/156/97 (H5N1) by 12% in HA1, prevented death but not
H5N1 infection in mice. Therefore, a DNA vaccine made with a
heterologous H5 strain did not prevent infection by H5N1 avian
influenza viruses in mice but was useful in preventing death.
*
Corresponding author. Mailing address: Department of
Virology and Molecular Biology, St. Jude Children's Research Hospital, 332 N. Lauderdale, Memphis, TN 38105. Phone: (901) 495-3400. Fax: (901)
523-2622. E-mail: Robert.Webster{at}stjude.org.
Journal of Virology, March 1999, p. 2094-2098, Vol. 73, No. 3
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Peiris, J. S. M., de Jong, M. D., Guan, Y.
(2007). Avian Influenza Virus (H5N1): a Threat to Human Health. Clin. Microbiol. Rev.
20: 243-267
[Abstract]
[Full Text]
-
Wang, S., Taaffe, J., Parker, C., Solorzano, A., Cao, H., Garcia-Sastre, A., Lu, S.
(2006). Hemagglutinin (HA) Proteins from H1 and H3 Serotypes of Influenza A Viruses Require Different Antigen Designs for the Induction of Optimal Protective Antibody Responses as Studied by Codon-Optimized HA DNA Vaccines. J. Virol.
80: 11628-11637
[Abstract]
[Full Text]
-
Gillim-Ross, L., Subbarao, K.
(2006). Emerging Respiratory Viruses: Challenges and Vaccine Strategies. Clin. Microbiol. Rev.
19: 614-636
[Abstract]
[Full Text]
-
Huber, V. C., McKeon, R. M., Brackin, M. N., Miller, L. A., Keating, R., Brown, S. A., Makarova, N., Perez, D. R., MacDonald, G. H., McCullers, J. A.
(2006). Distinct Contributions of Vaccine-Induced Immunoglobulin G1 (IgG1) and IgG2a Antibodies to Protective Immunity against Influenza.. CVI
13: 981-990
[Abstract]
[Full Text]
-
ONeill, E., Krauss, S. L., Riberdy, J. M., Webster, R. G., Woodland, D. L.
(2000). Heterologous protection against lethal A/HongKong/156/97 (H5N1) influenza virus infection in C57BL/6 mice. J. Gen. Virol.
81: 2689-2696
[Abstract]
[Full Text]
-
Cauthen, A. N., Swayne, D. E., Schultz-Cherry, S., Perdue, M. L., Suarez, D. L.
(2000). Continued Circulation in China of Highly Pathogenic Avian Influenza Viruses Encoding the Hemagglutinin Gene Associated with the 1997 H5N1 Outbreak in Poultry and Humans. J. Virol.
74: 6592-6599
[Abstract]
[Full Text]
-
Tumpey, T. M., Lu, X., Morken, T., Zaki, S. R., Katz, J. M.
(2000). Depletion of Lymphocytes and Diminished Cytokine Production in Mice Infected with a Highly Virulent Influenza A (H5N1) Virus Isolated from Humans. J. Virol.
74: 6105-6116
[Abstract]
[Full Text]
-
Dybing, J. K., Schultz-Cherry, S., Swayne, D. E., Suarez, D. L., Perdue, M. L.
(2000). Distinct Pathogenesis of Hong Kong-Origin H5N1 Viruses in Mice Compared to That of Other Highly Pathogenic H5 Avian Influenza Viruses. J. Virol.
74: 1443-1450
[Abstract]
[Full Text]
-
Epstein, S. L., Stack, A., Misplon, J. A., Lo, C.-Y., Mostowski, H., Bennink, J., Subbarao, K.
(2000). Vaccination with DNA encoding internal proteins of influenza virus does not require CD8+ cytotoxic T lymphocytes: either CD4+ or CD8+ T cells can promote survival and recovery after challenge. Int Immunol
12: 91-101
[Abstract]
[Full Text]
-
Lu, X., Tumpey, T. M., Morken, T., Zaki, S. R., Cox, N. J., Katz, J. M.
(1999). A Mouse Model for the Evaluation of Pathogenesis and Immunity to Influenza A (H5N1) Viruses Isolated from Humans. J. Virol.
73: 5903-5911
[Abstract]
[Full Text]